{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:01:59Z","timestamp":1779847319522,"version":"3.53.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG073442"],"award-info":[{"award-number":["R01AG073442"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-07475-x","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:56:16Z","timestamp":1776394576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with angiotensin II stimulating vs. inhibiting antihypertensive drug use in older adults"],"prefix":"10.1186","volume":"26","author":[{"given":"Nistha","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yuan David","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyongchiou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jung J.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"7475_CR1","unstructured":"Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017\u20132018. NCHS Data Brief. 2020;(364):1\u20138."},{"issue":"33","key":"7475_CR2","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/eurheartj\/ehy288","volume":"39","author":"JG Abell","year":"2018","unstructured":"Abell JG, Kivimaki M, Dugravot A, Tabak AG, Fayosse A, Shipley M, Sabia S, Singh-Manoux A. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018;39(33):3119\u201325.","journal-title":"Eur Heart J"},{"issue":"9","key":"7475_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/hr.2013.51","volume":"36","author":"S Yagi","year":"2013","unstructured":"Yagi S, Akaike M, Ise T, Ueda Y, Iwase T, Sata M. Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment. Hypertens Res. 2013;36(9):753\u20138.","journal-title":"Hypertens Res"},{"issue":"3","key":"7475_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/JAD-171119","volume":"62","author":"PG Kehoe","year":"2018","unstructured":"Kehoe PG. The Coming of Age of the Angiotensin Hypothesis in Alzheimer\u2019s Disease: Progress Toward Disease Prevention and Treatment? J Alzheimers Dis. 2018;62(3):1443\u201366.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"7475_CR5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","volume":"63","author":"T Ohrui","year":"2004","unstructured":"Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K, Arai H, Sasaki H. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology. 2004;63(7):1324\u20135.","journal-title":"Neurology"},{"key":"7475_CR6","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, Bicker J, Falcao A, Cruz MT, Fortuna A. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: Past, present and future. Ageing Res Rev. 2022;77:101612.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"7475_CR7","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1212\/WNL.0000000000010996","volume":"96","author":"JW van Dalen","year":"2021","unstructured":"van Dalen JW, Marcum ZA, Gray SL, Barthold D, van Moll EP, van Gool WA, Crane PK, Larson EB, Richard E. Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial. Neurology. 2021;96(1):e67\u201380.","journal-title":"Neurology"},{"issue":"1","key":"7475_CR8","doi-asserted-by":"publisher","first-page":"e2249370","DOI":"10.1001\/jamanetworkopen.2022.49370","volume":"6","author":"ZA Marcum","year":"2023","unstructured":"Marcum ZA, Gabriel N, Bress AP, Hernandez I. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries. JAMA Netw Open. 2023;6(1):e2249370.","journal-title":"JAMA Netw Open"},{"key":"7475_CR9","doi-asserted-by":"publisher","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465.","journal-title":"BMJ"},{"issue":"4","key":"7475_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2011-110347","volume":"26","author":"NM Davies","year":"2011","unstructured":"Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias. J Alzheimers Dis. 2011;26(4):699\u2013708.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"7475_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bcp.12511","volume":"79","author":"KL Goh","year":"2015","unstructured":"Goh KL, Bhaskaran K, Minassian C, Evans SJ, Smeeth L, Douglas IJ. Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink. Br J Clin Pharmacol. 2015;79(2):337\u201350.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"7475_CR12","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","volume":"80","author":"D Hwang","year":"2016","unstructured":"Hwang D, Kim S, Choi H, Oh IH, Kim BS, Choi HR, Kim SY, Won CW. Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002\u20132013). Circ J. 2016;80(11):2336\u201342.","journal-title":"Circ J"},{"issue":"3","key":"7475_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40615-024-01970-w","volume":"12","author":"E Jafari","year":"2025","unstructured":"Jafari E, Abuloha S, Alshehri A, Eljilany I, Aroza R, Guo J, Shao H. Racial\/Ethnic Disparities in Use of Angiotensin II Receptor Type 2\/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA. J Racial Ethn Health Disparities. 2025;12(3):1375\u201384.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"5","key":"7475_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","volume":"8","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, Aparasu RR, Morgan RO. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012;8(5):437\u201344.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"7475_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/2161-962X.1004","volume":"1","author":"TJ Vander Weele","year":"2012","unstructured":"Vander Weele TJ. Confounding and effect modification: distribution and measure. Epidemiol Methods. 2012;1(1):55\u201382.","journal-title":"Epidemiol Methods"},{"issue":"3","key":"7475_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.110.161950","volume":"57","author":"N Redmond","year":"2011","unstructured":"Redmond N, Baer HJ, Hicks LS. Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey. Hypertension. 2011;57(3):383\u20139.","journal-title":"Hypertension"},{"issue":"1","key":"7475_CR17","doi-asserted-by":"publisher","first-page":"e026652","DOI":"10.1161\/JAHA.122.026652","volume":"12","author":"SM Smith","year":"2023","unstructured":"Smith SM, Winterstein AG, Gurka MJ, Walsh MG, Keshwani S, Libby AM, Hogan WR, Pepine CJ, Cooper-DeHoff RM. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. J Am Heart Assoc. 2023;12(1):e026652.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"7475_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1345\/aph.1L368","volume":"43","author":"I Poon","year":"2009","unstructured":"Poon I, Lal LS, Ford ME, Braun UK. Racial\/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother. 2009;43(2):185\u201393.","journal-title":"Ann Pharmacother"},{"issue":"16","key":"7475_CR19","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s11606-022-07612-3","volume":"37","author":"TS Anderson","year":"2022","unstructured":"Anderson TS, Ayanian JZ, Zaslavsky AM, Souza J, Landon BE. National Trends in Antihypertensive Treatment Among Older Adults by Race and Presence of Comorbidity, 2008 to 2017. J Gen Intern Med. 2022;37(16):4223\u201332.","journal-title":"J Gen Intern Med"},{"key":"7475_CR20","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u20131324.","DOI":"10.1161\/HYP.0000000000000066"},{"issue":"7","key":"7475_CR21","first-page":"503","volume":"90","author":"C Armstrong","year":"2014","unstructured":"Armstrong C, Joint National C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503\u20134.","journal-title":"Am Fam Physician"},{"issue":"2","key":"7475_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ije\/dyu067","volume":"43","author":"A Sonnega","year":"2014","unstructured":"Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort Profile: the Health and Retirement Study (HRS). Int J Epidemiol. 2014;43(2):576\u201385.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"7475_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/workar\/wax032","volume":"4","author":"GG Fisher","year":"2018","unstructured":"Fisher GG, Ryan LH. Overview of the Health and Retirement Study and Introduction to the Special Issue. Work Aging Retire. 2018;4(1):1\u20139.","journal-title":"Work Aging Retire"},{"issue":"1","key":"7475_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/1475-6773.14065","volume":"58","author":"S Park","year":"2023","unstructured":"Park S, Wadhera RK, Jung J. Effects of Medicare eligibility and enrollment at age 65 years on the use of high-value and low-value care. Health Serv Res. 2023;58(1):174\u201385.","journal-title":"Health Serv Res"},{"issue":"5","key":"7475_CR25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1475-6773.2011.01277.x","volume":"46","author":"Y Gorina","year":"2011","unstructured":"Gorina Y, Kramarow EA. Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm. Health Serv Res. 2011;46(5):1610\u201327.","journal-title":"Health Serv Res"},{"issue":"7","key":"7475_CR26","doi-asserted-by":"publisher","first-page":"e2522833","DOI":"10.1001\/jamanetworkopen.2025.22833","volume":"8","author":"DJ Meyers","year":"2025","unstructured":"Meyers DJ, Werner RM. Studying Medicare Advantage With Existing Data-Pitfalls, Challenges, and Opportunities. JAMA Netw Open. 2025;8(7):e2522833.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7475_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/ajhp\/57.1.51","volume":"57","author":"S Benson","year":"2000","unstructured":"Benson S, Vance-Bryan K, Raddatz J. Time to patient discontinuation of antihypertensive drugs in different classes. Am J Health Syst Pharm. 2000;57(1):51\u20134.","journal-title":"Am J Health Syst Pharm"},{"key":"7475_CR28","doi-asserted-by":"crossref","unstructured":"Danaietash P, Verweij P, Wang JG, Dresser G, Kantola I, Lawrence MK, Narkiewicz K, Schlaich M, Bellet M. investigators P: Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan. J Clin Hypertens (Greenwich). 2022;24(7):804\u2013813.","DOI":"10.1111\/jch.14517"},{"issue":"6","key":"7475_CR29","first-page":"341","volume":"101","author":"DK Smith","year":"2020","unstructured":"Smith DK, Lennon RP, Carlsgaard PB. Managing Hypertension Using Combination Therapy. Am Fam Physician. 2020;101(6):341\u20139.","journal-title":"Am Fam Physician"},{"key":"7475_CR30","doi-asserted-by":"publisher","unstructured":"Ramos H, Moreno L, Perez-Tur J, Chafer-Pericas C, Garcia-Lluch G, Pardo J. CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints. J Pers Med. 2022;12(2):207. https:\/\/doi.org\/10.3390\/jpm12020207.","DOI":"10.3390\/jpm12020207"},{"issue":"3","key":"7475_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/01.HYP.0000200710.29498.80","volume":"47","author":"W Wang","year":"2006","unstructured":"Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006;47(3):403\u20139.","journal-title":"Hypertension"},{"issue":"2","key":"7475_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.116.09004","volume":"70","author":"JN Booth 3rd","year":"2017","unstructured":"Booth JN 3rd, Li J, Zhang L, Chen L, Muntner P, Egan B. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999\u20132012. Hypertension. 2017;70(2):275\u201384.","journal-title":"Hypertension"},{"issue":"3","key":"7475_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/WAD.0b013e31826cfe90","volume":"27","author":"Q Wu","year":"2013","unstructured":"Wu Q, Tchetgen Tchetgen EJ, Osypuk TL, White K, Mujahid M, Maria Glymour M. Combining direct and proxy assessments to reduce attrition bias in a longitudinal study. Alzheimer Dis Assoc Disord. 2013;27(3):207\u201312.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"7475_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72(6):558\u201369.","journal-title":"Korean J Anesthesiol"},{"issue":"18","key":"7475_CR35","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2015.15281","volume":"314","author":"P Li","year":"2015","unstructured":"Li P, Stuart EA, Allison DB. Multiple Imputation: A Flexible Tool for Handling Missing Data. JAMA. 2015;314(18):1966\u20137.","journal-title":"JAMA"},{"issue":"7","key":"7475_CR36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"7475_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","volume":"163","author":"P Cummings","year":"2009","unstructured":"Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438\u201345.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"7475_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/oxfordjournals.aje.a114593","volume":"125","author":"S Greenland","year":"1987","unstructured":"Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987;125(5):761\u20138.","journal-title":"Am J Epidemiol"},{"issue":"23","key":"7475_CR39","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"A Officers","year":"2002","unstructured":"Officers A. Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981\u201397.","journal-title":"JAMA"},{"issue":"11","key":"7475_CR40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.amjcard.2015.09.007","volume":"116","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Self WH, Zhu Y, Janke AT, Storrow AB, Levy P. Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012. Am J Cardiol. 2015;116(11):1717\u201323.","journal-title":"Am J Cardiol"},{"issue":"19","key":"7475_CR41","doi-asserted-by":"publisher","first-page":"e026432","DOI":"10.1161\/JAHA.122.026432","volume":"11","author":"Z Raisi-Estabragh","year":"2022","unstructured":"Raisi-Estabragh Z, Kobo O, Elbadawi A, Velagapudi P, Sharma G, Bullock-Palmer RP, Petersen SE, Mehta LS, Ullah W, Roguin A, et al. Differential Patterns and Outcomes of 20.6 Million Cardiovascular Emergency Department Encounters for Men and Women in the United States. J Am Heart Assoc. 2022;11(19):e026432.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"7475_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3810\/pgm.2014.01.2726","volume":"126","author":"I Chopra","year":"2014","unstructured":"Chopra I, Kamal KM, Candrilli SD, Kanyongo G. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia. Postgrad Med. 2014;126(1):66\u201377.","journal-title":"Postgrad Med"},{"issue":"3","key":"7475_CR43","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1016\/S2589-7500(21)00275-2","volume":"4","author":"T Nedelec","year":"2022","unstructured":"Nedelec T, Couvy-Duchesne B, Monnet F, Daly T, Ansart M, Gantzer L, Lekens B, Epelbaum S, Dufouil C, Durrleman S. Identifying health conditions associated with Alzheimer\u2019s disease up to 15 years before diagnosis: an agnostic study of French and British health records. Lancet Digit Health. 2022;4(3):e169\u201378.","journal-title":"Lancet Digit Health"},{"issue":"3","key":"7475_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ije\/15.3.413","volume":"15","author":"S Greenland","year":"1986","unstructured":"Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol. 1986;15(3):413\u20139.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"7475_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jgs.16202","volume":"68","author":"A Kumar","year":"2020","unstructured":"Kumar A, Rivera-Hernandez M, Karmarkar AM, Chou LN, Kuo YF, Baldwin JA, Panagiotou OA, Burke RE, Ottenbacher KJ. Social and Health-Related Factors Associated with Enrollment in Medicare Advantage Plans in Older Adults. J Am Geriatr Soc. 2020;68(2):313\u201320.","journal-title":"J Am Geriatr Soc"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07475-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:04:24Z","timestamp":1779843864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07475-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7475"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07475-x","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ohio State University\u2019s Institutional Review Board approved this study with waived patient consent because of the use of deidentified data. We used secondary data which have been deidentified by the Health and Retirement Study (HRS) and encrypted by National Institute of Aging Data LINKAGE Program (LINKAGE) and were available after restricted data use agreement. Therefore, the Ohio State University\u2019s Institutional Review Board approved this study with a waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"755"}}